We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.04%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$52.5B
AUM Growth
-$1.16B
(-2.2%)
Cap. Flow
-$399M
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
2,386
New
193
Increased
800
Reduced
1,005
Closed
184
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXO Logistics
GXO
|
+$161M |
| 2 |
Invivyd
IVVD
|
+$94.7M |
| 3 |
Freeport-McMoran
FCX
|
+$88.6M |
| 4 |
Amgen
AMGN
|
+$87.7M |
| 5 |
Truist Financial
TFC
|
+$83.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$296M |
| 2 |
Pfizer
PFE
|
+$276M |
| 3 |
Cisco
CSCO
|
+$151M |
| 4 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
+$103M |
| 5 |
Evergy
EVRG
|
+$99.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.48% |
| 2 | Technology | 20.59% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Protagonist Therapeutics
PTGX
$9.24B
| $2.33M | ﹤0.01% |
131,282
+69,267
| +112% | +$2.95M |
|
1002
First Bancorp
FBP
$4.22B
| $2.3M | ﹤0.01% |
175,103
+12,948
| +8% | +$159K |
|
1003
iShares Core S&P 500 ETF
IVV
$833B
| $2.3M | ﹤0.01% |
+5,334
| New | +$2.36M |
|
1004
Monro
MNRO
$381M
| $2.28M | ﹤0.01% |
39,700
-10,779
| -21% | -$632K |
|
|
BRSL
1005
Brightstar Lottery PLC
BRSL
$1.92B
| $2.27M | ﹤0.01% |
86,085
+78,257
| +1,000% | +$1.66M |
|
|
VRNT
1006
DELISTED
Verint Systems
VRNT
| $2.26M | ﹤0.01% |
+50,448
| New | +$2.19M |
|
|
IRBT
1007
DELISTED
iRobot
IRBT
| $2.25M | ﹤0.01% |
28,689
-77,468
| -73% | -$6.6M |
|
1008
Mission Produce
AVO
$1.09B
| $2.25M | ﹤0.01% |
122,193
+17,083
| +16% | +$336K |
|
1009
Cohu
COHU
$2.42B
| $2.23M | ﹤0.01% |
69,775
+31,482
| +82% | +$1.07M |
|
1010
Box
BOX
$4.76B
| $2.22M | ﹤0.01% |
93,806
-45,198
| -33% | -$1.11M |
|
|
CADE
1011
DELISTED
Cadence Bank
CADE
| $2.22M | ﹤0.01% |
74,481
-23,697
| -24% | -$661K |
|
1012
Fulton Financial
FULT
$4.48B
| $2.22M | ﹤0.01% |
145,075
-17,149
| -11% | -$265K |
|
1013
Enpro
NPO
$6.08B
| $2.21M | ﹤0.01% |
25,318
+2,562
| +11% | +$225K |
|
|
VGR
1014
DELISTED
Vector Group Ltd.
VGR
| $2.2M | ﹤0.01% |
243,642
+20,134
| +9% | +$196K |
|
1015
Old Republic International
ORI
$9.87B
| $2.19M | ﹤0.01% |
94,835
-2,442
| -3% | -$60.4K |
|
1016
SLM Corp
SLM
$4.75B
| $2.19M | ﹤0.01% |
124,338
+23,109
| +23% | +$434K |
|
1017
Universal Display
OLED
$3.51B
| $2.19M | ﹤0.01% |
12,780
-27,367
| -68% | -$5.67M |
|
1018
Diodes
DIOD
$4.12B
| $2.16M | ﹤0.01% |
23,884
+29
| +0.1% | +$2.53K |
|
1019
MiMedx Group
MDXG
$690M
| $2.16M | ﹤0.01% |
356,712
+354,066
| +13,381% | +$3.99M |
|
1020
Movado Group
MOV
$735M
| $2.16M | ﹤0.01% |
68,668
-17,541
| -20% | -$561K |
|
1021
XPEL
XPEL
$1.26B
| $2.16M | ﹤0.01% |
28,490
-100,715
| -78% | -$8.29M |
|
1022
Financial Institutions
FISI
$793M
| $2.15M | ﹤0.01% |
70,182
+7,906
| +13% | +$239K |
|
1023
Healthcare Services Group
HCSG
$1.5B
| $2.15M | ﹤0.01% |
86,023
+3,984
| +5% | +$108K |
|
1024
Graco
GGG
$12.4B
| $2.15M | ﹤0.01% |
30,658
-45,216
| -60% | -$3.47M |
|
1025
Peapack-Gladstone Financial
PGC
$798M
| $2.14M | ﹤0.01% |
64,083
+6,710
| +12% | +$216K |
|
Similar funds
Federated Hermes's Q3 2021 Portfolio in Review
As of Q3 2021, Federated Hermes held 2,386 positions worth $52.5B, down 2.2% from $53.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Federated Hermes's Q3 2021 filing shows 193 new, 800 increased, 1,005 reduced and 184 closed positions. Its largest new stake was GXO Logistics: 2,051,695 shares worth $161M. The largest sale was Moderna, an estimated $296M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q3 2021 buy was GXO Logistics: 2,051,695 shares worth $161M.
- Federated Hermes added most to Freeport-McMoran in Q3 2021, an estimated $88.6M increase.
- Federated Hermes's biggest Q3 2021 reduction was Moderna, cutting an estimated $296M.
- Federated Hermes fully exited Translate Bio, Inc. Common Stock in Q3 2021, selling an estimated $103M.
- Federated Hermes's ten largest holdings make up 12% of its $52.5B portfolio in Q3 2021.
- Federated Hermes opened 193 new positions and closed 184 in Q3 2021.
- Federated Hermes's portfolio value fell 2.2% quarter-over-quarter to $52.5B.
Based on Federated Hermes's 13F filing for Q3 2021, filed 15 Nov 2021.